Search / Trial NCT06235359

Is Intercostal Tube Enough in Management of Empyema

Launched by ASSIUT UNIVERSITY · Jan 30, 2024

Trial Information

Current as of December 21, 2024

Not yet recruiting

Keywords

ClinConnect Summary

Empyema refers to presence of pus in the pleural space -Causes Primary: bacterial Pneumonia (staph aureus, strept pneumonia , H.influenza) , TB

Secondry :

PostTraumati postoperative :open heart , esophageal, mediastinum , lung rupture of lung absess

-pathophysiology and stages During an inflammatory process such as pneumonia, there is an increase in fluid production in the pleural cavity known as the exudate stage. As the disease progresses microorganisms, usually bacteria, can colonize the fluid and generated an empyema. This fluid is characterized by elevated lactate dehydrogenase, pro...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients admitted to Assuit university Hospital and diagnosed with empyema
  • Exclusion Criteria:
  • Patient diagnosed with Post-operative empyema
  • Patient diagnosed with post traumatic empyema
  • Patient diagnosed with Bronchopleural fistula
  • Patient diagnosed with TB

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0